PA
BYRN icon

PharVision Advisers’s Byrna Technologies BYRN Stock Holding History

PharVision Advisers’s Portfolio BYRN Stock Details BYRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,913
Closed -$419K – 721
2025
Q3 		$419K Buy
+18,913
New +$420K 0.24% 64

Other funds holding BYRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

PharVision Advisers's BYRN Position: Q4 2025 in Review

PharVision Advisers sold out of Byrna Technologies (BYRN) in Q4 2025, closing a stake of 18,913 shares — an estimated $419K sold.

PharVision Advisers first reported a position in BYRN in Q3 2025 and held it in 1 quarter. The position peaked at $419K in Q3 2025. 128 funds tracked by Wall St. Rank hold BYRN as of Q4 2025.

  • PharVision Advisers reported no remaining Byrna Technologies position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 18,913 Byrna Technologies shares in Q4 2025, an estimated $419K.
  • PharVision Advisers first reported a position in Byrna Technologies in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Byrna Technologies position peaked at $419K in Q3 2025.
  • 128 funds tracked by Wall St. Rank held Byrna Technologies as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.